Latest Capital Raise News

Weebit Nano Ltd (ASX: WBT) has opened a non-underwritten Share Purchase Plan (SPP) offering eligible shareholders in Australia and New Zealand the chance to buy up to A$30,000 worth of shares at A$4.05 each. The company aims to raise up to A$15 million to support the commercialisation of its Resistive RAM (ReRAM) technology.

ARC Funds Limited (ASX: ARC) has entered a conditional agreement to acquire a 25% minority equity interest in Ausbiz Group Pty Ltd by issuing over 8 million shares to Ausbiz shareholders, subject to customary conditions including shareholder approval.

Radiopharm Theranostics has secured a clinical supply agreement with Siemens Healthineers to manufacture and distribute RAD101, advancing its Phase 3 trial in the U.S. Interim Phase 2b data showed 90% concordance with MRI in detecting brain metastases.

Orange Minerals NL has agreed to sell certain tenements of its Majestic Project in Western Australia to Auravelle Metals Limited, receiving $200,000 in Auravelle shares as consideration. This move aligns with Orange Minerals' strategy to focus on core assets like its Tepa gold project in Ghana.

NEXTDC Limited (ASX:NXT) has announced a A$1 billion wholesale offer of subordinated hybrid securities, fully backed by a binding commitment from Canadian investment group La Caisse. The capital raise aims to support NEXTDC’s growth strategy and infrastructure expansion through to FY29.

Janus Electric has appointed Lynx Advisors and Spark Plus to bolster its capital strategy and investor engagement while settling longstanding disputes with Kjøller A/S. The company also ends its agreement with EVUNI, opening new partnership opportunities.

Ardea Resources has successfully raised $340,000 through a Shareholder Purchase Plan following a $5 million placement, demonstrating shareholder confidence despite ongoing geopolitical tensions.

Noble Helium has raised $12 million through a strongly supported institutional placement to fund its North Rukwa helium exploration in Tanzania, responding to tightening global helium supplies.

Buxton Resources has raised approximately A$3 million through a well-supported share placement, aiming to fast-track drilling and exploration across key Australian projects.

Way2VAT has successfully raised A$2.6 million through a share placement, aiming to repay short-term debt and fund its strategic expansion plans. Investors have shown strong support, agreeing to a six-month escrow on their shares.

Pathkey.AI has secured a significant commercial contract with Imunexus Therapeutics, deploying its AI-driven TrialKey platform to enhance early-phase clinical trial design and capital raising efforts.

KMD Brands has successfully completed a $44.2 million institutional equity raise as part of a larger $58.5 million entitlement offer, setting the stage for its retail offer opening next week.